Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007
Clinical trial NCT03853798 · COMPLETED
Trial details
- NCT number
- NCT03853798
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-21
- Primary completion
- 2024-07-03
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.